BR0202157A - Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo - Google Patents

Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo

Info

Publication number
BR0202157A
BR0202157A BR0202157-9A BR0202157A BR0202157A BR 0202157 A BR0202157 A BR 0202157A BR 0202157 A BR0202157 A BR 0202157A BR 0202157 A BR0202157 A BR 0202157A
Authority
BR
Brazil
Prior art keywords
amino acid
peptide obtained
scorpion venom
hypotensive agent
peptide
Prior art date
Application number
BR0202157-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Adriano Monteiro De Ca Pimenta
Maria Elena De Li Perez-Garcia
Carlos Ribeiro Diniz
Robson Augusto Souza Do Santos
Pierre Edouard Bougis
Marie-France Eauclaire
Original Assignee
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minas Gerais filed Critical Univ Minas Gerais
Priority to BR0202157-9A priority Critical patent/BR0202157A/pt
Priority to DE60325227T priority patent/DE60325227D1/de
Priority to US10/517,097 priority patent/US7192925B2/en
Priority to AT03724688T priority patent/ATE417061T1/de
Priority to EP03724688A priority patent/EP1534743B1/en
Priority to PCT/BR2003/000073 priority patent/WO2003104274A1/en
Priority to AU2003229155A priority patent/AU2003229155A1/en
Publication of BR0202157A publication Critical patent/BR0202157A/pt
Priority to US11/687,785 priority patent/US20070275901A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR0202157-9A 2002-06-07 2002-06-07 Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo BR0202157A (pt)

Priority Applications (8)

Application Number Priority Date Filing Date Title
BR0202157-9A BR0202157A (pt) 2002-06-07 2002-06-07 Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo
DE60325227T DE60325227D1 (enExample) 2002-06-07 2003-06-09
US10/517,097 US7192925B2 (en) 2002-06-07 2003-06-09 Scorpion peptide as hypotensive agent
AT03724688T ATE417061T1 (de) 2002-06-07 2003-06-09 Scorpionpeptid als blutdrucksenkendes mittel
EP03724688A EP1534743B1 (en) 2002-06-07 2003-06-09 Scorpion peptide as hypotensive agent
PCT/BR2003/000073 WO2003104274A1 (en) 2002-06-07 2003-06-09 Scorpion peptide as hypotensive agent
AU2003229155A AU2003229155A1 (en) 2002-06-07 2003-06-09 Scorpion peptide as hypotensive agent
US11/687,785 US20070275901A1 (en) 2002-06-07 2007-03-19 Synthesis, modification and reduction of primary structure of hypotensive peptides present in scorpion venom for optimizing their use as a hypotensive medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0202157-9A BR0202157A (pt) 2002-06-07 2002-06-07 Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo

Publications (1)

Publication Number Publication Date
BR0202157A true BR0202157A (pt) 2005-04-12

Family

ID=38750221

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0202157-9A BR0202157A (pt) 2002-06-07 2002-06-07 Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo

Country Status (7)

Country Link
US (2) US7192925B2 (enExample)
EP (1) EP1534743B1 (enExample)
AT (1) ATE417061T1 (enExample)
AU (1) AU2003229155A1 (enExample)
BR (1) BR0202157A (enExample)
DE (1) DE60325227D1 (enExample)
WO (1) WO2003104274A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0202157A (pt) * 2002-06-07 2005-04-12 Univ Minas Gerais Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo
EP2029157A4 (en) * 2006-05-19 2009-11-18 Georgia Tech Res Inst ABC TRANSPORTERLIGAND
WO2008008873A2 (en) * 2006-07-14 2008-01-17 Georgia Tech Research Corporation Clc channel ligand

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
IL104419A0 (en) 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5494895A (en) * 1993-07-22 1996-02-27 Merck & Co., Inc. Scorpion peptide margatoxin with immunosuppressant activity
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US6569891B1 (en) * 2000-05-19 2003-05-27 Brigham Young University Antihypertensive compound from Caesalpinia brasiliensis
BR0202157A (pt) * 2002-06-07 2005-04-12 Univ Minas Gerais Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo

Also Published As

Publication number Publication date
EP1534743A1 (en) 2005-06-01
AU2003229155A1 (en) 2003-12-22
ATE417061T1 (de) 2008-12-15
WO2003104274A1 (en) 2003-12-18
US7192925B2 (en) 2007-03-20
DE60325227D1 (enExample) 2009-01-22
US20070275901A1 (en) 2007-11-29
EP1534743B1 (en) 2008-12-10
US20060014928A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
ATE458054T1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
DE69824755D1 (de) Cytokinähnliches polypeptid-10 aus säugetieren
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
CA2352537A1 (en) Tgf.beta.1-inhibitor peptides
BR0208183A (pt) Peptìdeo modificado por wt1
DK66391A (da) Terapeutisk virksomme peptider
DE69731097D1 (de) Conotoxin peptid pviia
BR9810478A (pt) Análogos de hormÈnio glicoproteìna reticulados por dissulfeto e sua preparação e utilização
DE60238330D1 (de) Immunologisch bedeutende herpes-simplex-virus-antigene und verfahren für ihre verwendung
PT1417222E (pt) Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
AU2003229155A1 (en) Scorpion peptide as hypotensive agent
ATE291033T1 (de) Therapeutische peptide
BR0014803A (pt) Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição de diagnóstico
ATE420890T1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide
SE9700301D0 (sv) New compound
ATE521635T1 (de) Physiologisch wirksamer komplex mit tnf aktivität
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
DK1778271T3 (da) Peptid til behandling af herpesvirusinfektioner
ATE510008T1 (de) Entzündungshemmende peptide
CA2530731A1 (en) Peptide having apoptosis-inhibiting activity
DK1569961T3 (da) Splice variant af det menneskelige hypofysevæksthormon

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1980 DE 16/12/2008 POR TER SIDO FEITA A CONCILIACAO DO PAGAMENTO DA ANUIDADE.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1980 DE 16/12/2008.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AOS DESPACHOS 8.6 DA RPI 2016 DE 25/08/2009 E 8.11 DA RPI 2028 DE 17/11/2009 POR TEREM SIDO INDEVIDOS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]